Swiss stocks - Factors to watch on November 1

Obseva SA

01/11/2021 05:53

ZURICH/BERLIN, Nov 1 (Reuters) - Here are some of the main
factors that may affect Swiss stocks on Monday:

    COMPANY STATEMENTS
    * Novartis AG  NOVN.S  said the U.S. Food and Drug
Administration (FDA) had approved Scemblix (asciminib), for the
treatment of chronic myeloid leukaemia  NOVN.S 
    * Obseva SA  OBSN.S  said Chief Financial Officer David
Renas will step down from his position for personal reasons,
effective January 5, 2022.  OBSN.S 
    * Glarner Kantonalbank  GLKBN.S  said net operating profit
dropped by 5.4% to 21.0 million Swiss francs in the first nine
months of the year. GLKBN.S 

    ECONOMY
    Swiss October manufacturing PMI due at 0830 GMT
    SNB data on Swiss sight deposits due at 0900 GMT

 (Reporting by Zurich newsroom and Berlin Speed Desk)
 ((+41 58 306 7336; zurich.newsroom@thomsonreuters.com))
 
((For Top News in a multimedia Web format on Eikon visit: https://bit.ly/2NDFd6g
FOR RELATED PRICES, NEWS AND OTHER TOPICS, DOUBLE-CLICK ON:
Daily Swiss stock market report in German  .SDE 
All SMI constituent stocks  0#.SSMI 
DJ STOXX index  .STOXX 
Top 10 STOXX sectors  .PGL.STOXXS 
Top 10 EUROSTOXX sectors  .PGL.STOXXES 
Swiss mid-cap index  .SSMI 
Swiss all-share index  .SSHI 
Swiss market digest  .AD.S 
Sector overview  CH/SECTOR1 
All Swiss news  CH 
Swiss research news  CH-RCH   
All equity news  E 
SPEED GUIDES:   EQUITY   EQUITY/NEWS1   EUR/EQUITY   SWITZERLAND   REUTERS  ))